U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H13NO3.C4H6O6
Molecular Weight 333.2913
Optical Activity ( - )
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EPINEPHRINE BITARTRATE

SMILES

O[C@H]([C@@H](O)C(O)=O)C(O)=O.CNC[C@H](O)C1=CC=C(O)C(O)=C1

InChI

InChIKey=YLXIPWWIOISBDD-NDAAPVSOSA-N
InChI=1S/C9H13NO3.C4H6O6/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;5-1(3(7)8)2(6)4(9)10/h2-4,9-13H,5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;1-,2-/m01/s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
EPINEPHRINE BITARTRATE
JAN   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD  
Common Name English
ADRENALINE (AS TARTRATE)
Common Name English
EPINEPHRINE BITARTRATE COMPONENT OF LIGNOSPAN FORTE
Common Name English
EPINEPHRINE BITARTRATE [JAN]
Common Name English
EPINEPHRINE D-BITARTRATE [MI]
Common Name English
ADRENALIN TARTRATE [WHO-IP]
Common Name English
(-)-3,4-DIHYDROXY-.ALPHA.-((METHYLAMINO)METHYL)BENZYL ALCOHOL (+)-TARTRATE (1:1) SALT.
Common Name English
ADRENALINE TARTRATE [EP MONOGRAPH]
Common Name English
ADRENALINE ACID TARTRATE [MART.]
Common Name English
MEDIHALER-EPI
Brand Name English
Epinephrine bitartrate [WHO-DD]
Common Name English
EPINEPHRINE BITARTRATE [ORANGE BOOK]
Common Name English
1,2-BENZENEDIOL, 4-(1-HYDROXY-2-(METHYLAMINO)ETHYL)-, (R)-, (R-(R*,R*))-2,3-DIHYDROXYBUTANEDIOATE (1:1) (SALT)
Common Name English
EPINEPHRINE HYDROGEN TARTRATE [WHO-IP]
Common Name English
NSC-756755
Code English
EPINEPHRINE BITARTRATE [VANDF]
Common Name English
ADRENALINE TARTRATE
EP  
Systematic Name English
LIGNOSPAN FORTE COMPONENT EPINEPHRINE BITARTRATE
Common Name English
EPINEPHRINI HYDROGENOTARTRAS [WHO-IP LATIN]
Common Name English
BRONITIN
Brand Name English
EPINEPHRINE TARTRATE
Common Name English
ADRENALINE ACID TARTRATE
MART.  
Common Name English
EPINEPHRINE BITARTRATE [USP MONOGRAPH]
Common Name English
EPINEPHRINE BITARTRATE [USP-RS]
Common Name English
ADRENALINE BITARTATE
Common Name English
L-EPINEPHRINE HYDROGEN TARTRATE
Common Name English
Classification Tree Code System Code
CFR 21 CFR 341.16
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
NCI_THESAURUS C87053
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
Code System Code Type Description
NSC
756755
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
MERCK INDEX
m4944
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY Merck Index
WHO INTERNATIONAL PHARMACOPEIA
EPINEPHRINE BITARTRATE
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY Other name: Adrenalin tartrate. (In certain countries the name Adrenalin is a trademark: In those countries this name may beused only when applied to the product issued by the owners of the trademark.)Description: A white to greyish white, crystalline powder; odourless.Solubility: Soluble in 3 parts of water; slightly soluble in ethanol (~750 g/l) TS; practically insoluble in ether R.Category. Sympathomimetic.Storage: Epinephrine hydrogen tartrate should be kept in a tightly closed container, protected from light.Additional information: Epinephrine hydrogen tartrate gradually darkens in colour on exposure to air and light. Even in theabsence of light, Epinephrine hydrogen tartrate is gradually degraded on exposure to a humid atmosphere, the decompositionbeing faster at higher temperatures.Definition: Epinephrine hydrogen tartrate contains not less than 98.0% and not more than 101.0% of C9H13NO3,C4H6O6,calculated with reference to the dried substance.
ECHA (EC/EINECS)
200-097-1
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
DRUG BANK
DBSALT000788
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
FDA UNII
30Q7KI53AK
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
CAS
51-42-3
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
EVMPD
SUB01911MIG
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
RXCUI
203180
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY RxNorm
SMS_ID
100000087265
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
EVMPD
SUB72751
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
EPA CompTox
DTXSID3049415
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
RS_ITEM_NUM
1237000
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
ChEMBL
CHEMBL679
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
DAILYMED
30Q7KI53AK
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
NCI_THESAURUS
C48021
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
PUBCHEM
5815
Created by admin on Fri Dec 15 15:10:52 UTC 2023 , Edited by admin on Fri Dec 15 15:10:52 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of EPINEPHRINE
PARENT (SALT/SOLVATE)
Structure of TARTARIC ACID
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966